Page last updated: 2024-08-23

acifran and Dyslipidemia

acifran has been researched along with Dyslipidemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boatman, PD; Richman, JG; Semple, G	1
Chen, R; Connolly, DT; Dang, TH; Pride, CC; Richman, JG; Sage, CR; Semple, G; Skinner, PJ; Tamura, SY; Webb, PJ	1

Reviews

1 review(s) available for acifran and Dyslipidemia

Article	Year
Nicotinic acid receptor agonists. Journal of medicinal chemistry, 2008, Dec-25, Volume: 51, Issue:24 Topics: Animals; Chemistry, Pharmaceutical; Drug Design; Dyslipidemias; Humans; Kinetics; Ligands; Mice; Models, Chemical; Nicotinic Agonists; ortho-Aminobenzoates; Receptors, G-Protein-Coupled; Receptors, Nicotinic	2008

Other Studies

1 other study(ies) available for acifran and Dyslipidemia

Article	Year
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b. Bioorganic & medicinal chemistry letters, 2009, Aug-01, Volume: 19, Issue:15 Topics: Animals; Atherosclerosis; Carboxylic Acids; Chemistry, Pharmaceutical; CHO Cells; Cricetinae; Cricetulus; Drug Design; Dyslipidemias; Humans; Ligands; Lipoproteins, HDL; Lipoproteins, LDL; Models, Chemical; Niacin; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic	2009

Article

Year

5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b.

Bioorganic & medicinal chemistry letters, 2009, Aug-01, Volume: 19, Issue:15

Topics: Animals; Atherosclerosis; Carboxylic Acids; Chemistry, Pharmaceutical; CHO Cells; Cricetinae; Cricetulus; Drug Design; Dyslipidemias; Humans; Ligands; Lipoproteins, HDL; Lipoproteins, LDL; Models, Chemical; Niacin; Pyrazoles; Receptors, G-Protein-Coupled; Receptors, Nicotinic

2009